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White matter changes in the perforant path area in patients with amyotrophic lateral sclerosis
Objective: The aim of this study was to test the hypoth-
esis that white matter degeneration of the perforant
path – as part of the Papez circuit – is a key feature of
amyotrophic lateral sclerosis (ALS), even in the absence
of frontotemporal dementia (FTD) or deposition of
pTDP-43 inclusions in hippocampal granule cells.
Methods: We used diffusion Magnetic Resonance Imag-
ing (dMRI), polarized light imaging (PLI) and immuno-
histochemical analysis of post mortem hippocampus
specimens from controls (n = 5) and ALS patients
(n = 14) to study white matter degeneration in the per-
forant path. Results: diffusion Magnetic Resonance
Imaging demonstrated a decrease in fractional aniso-
tropy (P = 0.01) and an increase in mean diffusivity
(P = 0.01) in the perforant path in ALS compared to
controls. PLI-myelin density was lower in ALS (P =
0.05) and correlated with fractional anisotropy
(r = 0.52, P = 0.03). These results were confirmed by
immunohistochemistry; both myelin (proteolipid protein,
P = 0.03) and neurofilaments (SMI-312, P = 0.02) were
lower in ALS. Two out of the fourteen ALS cases showed
pTDP-43 pathology in the dentate gyrus, but with com-
parable myelination levels in the perforant path to other
ALS cases. Conclusion: We conclude that degeneration
of the perforant path occurs in ALS patients and that
this may occur before, or independent of, pTDP-43
aggregation in the dentate gyrus of the hippocampus.
Future research should focus on correlating the degree
of cognitive decline to the amount of white matter atro-
phy in the perforant path.
Keywords: amyotrophic lateral sclerosis, diffusion MRI, frontotemporal dementia, hippocampus, perforant path,
polarized light imaging
Introduction
Amyotrophic lateral sclerosis (ALS) is a motor neuron
disease that is primarily characterized by a loss of
motor neurons in the brain and spinal cord causing
dysfunction of voluntary movement. A significant pro-
portion of ALS patients develop cognitive impairment
in the form of frontotemporal dementia (FTD). It is esti-
mated that up to ~13% of the patients with ALS meet
the criteria for FTD, with an additional ~35% demon-
strating some form of cognitive impairment [1,2]. In
addition to the symptomatic overlap between ALS and
FTD, pathological aggregation of phosphorylated
43 kDa TAR DNA-binding protein (pTDP-43) [3,4] is
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reported in almost all cases of ALS and in the largest
subset of FTD (behavioural variant FTD: bvFTD) sup-
porting the concept that ALS and FTD are part of the
same pathological spectrum [4,5].
A pathological staging system in ALS and bvFTD,
based on the regional distribution of pTDP-43, high-
lights the involvement of several cortical regions that
connect with each other via the Papez circuit in both
diseases [5–7]. The Papez circuit (Figure 1) – comprised
of the hippocampal formation, mammillary bodies,
anterior thalamic nuclei and anterior cingulate – is a
principal pathway of the limbic system associated with
the formation and consolidation of episodic memory
[8,9]. Recent evidence recognizes episodic memory defi-
cits in bvFTD [10]. These deficits are supported by
in vivo MRI volumetric analyses that demonstrate regio-
nal grey and white matter atrophy of the Papez circuit
[11,12]. Furthermore, volumetric analysis on post mor-
tem brains demonstrated reduced grey matter volume,
while white matter connectivity was not investigated
[11]. Less is known about the involvement of the Papez
circuitry in patients with ALS. Previous studies have
demonstrated a relationship between pTDP-43 pathol-
ogy in ALS patients and their cognitive decline [6,13],
suggesting a relation to limbic system impairment. Fur-
thermore, an accumulating body of evidence supports
involvement of the perforant pathway, the tract con-
necting the entorhinal cortex with the hippocampal
formation as part of the Papez circuit, in late stages of
ALS [14,15]. This is concomitant with the presence
(not severity) of pTDP-43 accumulation and neuronal
degeneration in the dentate gyrus area in pure ALS
patients with memory impairment [16,17]. Here,
regions connected by the perforant path were affected;
laminar spongiosis was found in the dentate gyrus and
in two severe cases also in the subiculum, as was visu-
alized with standard haematoxylin and eosin staining.
The spongiosis in the dentate gyrus may be the result
of degenerating axons (originating from the entorhinal
cortex) that no longer terminate in the molecular layer
of the dentate gyrus. However, white matter alterations
were not directly investigated in this study.
In recent years, advances in diffusion Magnetic Reso-
nance Imaging (dMRI) have attracted researchers to
study white matter tissue integrity noninvasively. dMRI
infers tissue microstructure from the diffusion profile of
water within tissue [18]. The diffusion profile is gener-
ally characterized using the metrics mean diffusivity
(mean apparent diffusion across all directions), frac-
tional anisotropy (the degree of diffusion directionality),
and the principal diffusion direction. These metrics are
sensitive to changes in nervous tissue (e.g. demyelina-
tion) following neurodegenerative disorders or trau-
matic brain injury [19]. As such, dMRI is currently a
widely accepted imaging modality for studying patients
with various neurodegenerative diseases (see Goveas
et al. for an excellent overview [20]). However, axon
density, packing and myelination all alter the diffusion
signal [21], muddying the interpretation of dMRI signal
changes. To truly identify the origin of dMRI signal
changes, histological examination of tissue remains
essential. Therefore, ex vivo dMRI is rapidly evolving to
study post mortem brain tissue and facilitates subse-
quent comparison to microscopy [22]. A further advan-
tage is the use of high-field MRI systems and longer
acquisition times that offers imaging at much higher
resolution with ex vivo dMRI. With the estimation of
fibre orientations at each voxel, dMRI tractography
allows one to reconstruct white matter bundles. Appli-
cation of in vivo dMRI tractography to delineate the
perforant path is challenging because of limited spatial
resolution to capture its small size. The use of high-
resolution ex vivo dMRI previously showed to be suitable
for reconstructing the perforant path in post mortem
hippocampus specimens [23].
To assess the white matter alterations in the perforant
path of patients with ALS, we propose to combine
ex vivo dMRI with subsequent analysis of the microstruc-
tural changes using immunohistochemistry (IHC) and
polarized light imaging (PLI). PLI quantifies myelin den-
sity and the orientation of axons based on birefringence
of the myelin sheath [24]. The comparison was made in
post mortem hippocampus specimens from ALS patients
and healthy controls. We hypothesize that white matter
degeneration of the perforant path – as part of the Papez
circuit – in the hippocampus is a feature of ALS, even in
the absence of fully developed FTD or deposition of
pTDP-43 inclusions in hippocampal granule cells. We
specifically selected the hippocampus for studying white
matter integrity in the Papez circuit, because this is the
only area of the Papez circuit that shows TDP-43 inclu-
sions in both ALS and FTD [7]. The results presented in
this study may provide insight into the earliest neural
substrate of FTD-like symptoms observed in ALS and
contribute to the broader hypothesis that ALS and FTD
may form part of a disease continuum.
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Methods
Tissue specimens
For this study, fourteen post mortem ALS human
brains were acquired from the Oxford Brain Bank,
Nuffield Department of Clinical Neurosciences, Univer-
sity of Oxford, United Kingdom. Five age-matched post
mortem human control brains were acquired via the
body donor programme at the Department of Anat-
omy of the Radboud University Medical Center, Nij-
megen, Netherlands. The brains were removed from
the skull and fixed in 10% formalin. Details on the
history of each specimen are listed in Table 1. All
brains were cut in coronal slabs of 10 mm thickness
and the hippocampi were sampled from a slab com-
prising the lateral geniculate nucleus as a key
anatomical landmark. ALS classification was based on
the neuropathological assessment of pTDP-43 pro-
teinopathy in gatekeeper regions previously defined
by Tan et al. [7]. These include, the hypoglossal
nucleus, the motor cortex, the anterior cingulate cor-
tex, the rhinal cortex and the amygdala. pTDP-43
pathology/severity in these regions is used to estab-
lish an ALS staging for each subject (see Table 1)
[7]. To assess whether the subjects also demonstrated
signs of FTD pathology, we checked for pTDP-43
pathology in the dentate gyrus of the hippocampus
specimens [7]. Representative blocks of thirteen other
brain regions (Table S1) were sampled and stained
following standard brain banking protocol for diag-
nostic purposes [25].
MRI acquisition
Prior to scanning, all specimens were drained of for-
malin and rehydrated in phosphate buffered saline
(PBS) (0.1 M, pH = 7.4) for at least 24 h to increase
the T2-relaxation rates close to in vivo levels. Formalin
fixation is known to reduce T2-relaxation rates of tis-
sue; thus lowering the MRI signal [26]. Following
rehydration, the specimens were placed in a 100 ml
syringe filled with fluorinert (Solvay Solexis Inc), a
proton-free liquid which is susceptibility matched to
brain tissue. All scans were performed at room tem-
perature on a 11.7T Bruker BioSpec Avance III pre-
clinical MR system (Bruker BioSpin, Ettlingen,
Germany) using a birdcage coil (Bruker Biospin).
Anatomical scans were acquired with a T1-weighted
fast low angle shot gradient echo (FLASH) sequence at
a resolution of 0.1 9 0.1 9 0.1 mm (TR = 25 ms,
TE = 3.4 ms, flip angle = 10°).
Figure 1. The circuit of Papez with a schematic representation of the hippocampal formation. The perforant path (blue) starts in the
entorhinal cortex and projects through the subiculum via the molecular layer of the hippocampus to the dentate gyrus and the CA3
region of the hippocampus (circled-cross indicates out of screen – i.e. anterior-posterior – orientation). The alvear path (yellow) projects
via the CA1 region into the hippocampus. CA, cornu ammonis; DG, dentate gyrus; EC, entorhinal cortex; PaS, parasubiculum; PreS,
presubiculum; Sub, subiculum.
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Diffusion weighted images were obtained using a
spin-echo sequence with an EPI readout in four seg-
ments (TR = 13.75 s, TE = 30.1 ms, Δ = 12.5 ms, d =
4.0 ms). Sixty-four gradient directions were acquired
at b = 4000 s/mm2, in addition to six images with
negligible diffusion weighting (b = 14 s/mm2). The
specimens were covered in the coronal plane of the scan-
ner with a field-of-view of 28.8 9 28.8 mm, 72 9 72
matrix, and slice thickness of 0.4 mm, yielding a
0.4 9 0.4 9 0.4 mm resolution. The number of slices
varied between 80 and 100 depending on the size of
each specimen.
MRI analysis
Processing of all MR images was performed with FSL
(FMRIB’s Software Library) [27]. First, eddy current
correction was performed using EDDY and each volume
was aligned using a 3D affine transformation. A diffu-
sion tensor was then estimated at each voxel in the
dMRI data. Four different microstructural metrics were
derived from this diffusion tensor fractional anisotropy
(FA), mean diffusivity (MD), axial diffusivity (AD) and
radial diffusivity (RD). These metrics are broadly known
to be sensitive to tissue microstructure, but not to be
highly specific to a single microstructural property. FA
describes the diffusion directionality of water ranging
from 0 (no directionality of water diffusion, i.e. isotro-
pic diffusion) to 1 (water diffusion along a single direc-
tion only). FA in white matter is generally high, but
may be decreased in the presence of axonal/myelin
degeneration. MD is a measure for the average diffusiv-
ity in a voxel and is inversely sensitive to necrosis,
oedema and membrane permeability [28]. AD and RD
disentangle the FA into diffusivity parallel and perpen-
dicular to the fibre orientation, respectively. An
increase in RD was previously shown to correlate with
a reduction in myelin [29], but would also be expected
to increase if fibre density decreases.
To delineate the perforant path in all the hippocam-
pus specimens, we performed probabilistic tractography
using the dMRI data. First, we estimated the fibre con-
figuration in each voxel using the Bedpostx algorithm
[30]. We fitted up to three fibre orientations within
each voxel in a data-driven way that only estimates
additional fibres if their existence is statistically sup-
ported by the data. Probabilistic tractography was then
performed using the probtrackx2 algorithm [31].
Table 1. Post mortem specimen details from control and ALS brains. The pTDP-43 staging is based upon the staging scheme proposed by
Tan et al. [7]
Group Sex Age (years) PMI (days) FT (months)
pTDP-43
staging
ALS-FTD
phenotype
Controls (n = 5) Male 67 0.5 12 -
61 0.5 14 -
73 0.5 8.5 -
Female 82 0.5 8 -
71 1 15 -
Mean (SD) 70.8 (7.8) 0.6 (0.2) 11.5 (3.2) -
ALS (n = 14) Male 82 3 42 1
76 4 39 Missing
78 2 36 1
55 4 14 4
Female 61 4 47 1
64 2 45 1 Yes
77 Unknown Unknown 1
53 5 42 1
81 1 36 2
81 2 35 4 Yes
80 2 26 2
67 2 15 2
74 2 14 2
53 2 13 Missing
Mean (SD) 70.1 (11.0) 2.7 (1.2) 29.9 (12.8) 1.8 (1.1)
DG, dentate gyrus; FT, fixation time; PMI, post mortem interval; SD, standard deviation.
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There is extensive animal literature describing the
perforant pathway system in the hippocampus [32–
34], while observations from human studies are slowly
increasing (see for example Zeineh et al. [35,36]). To
give a brief overview of its trajectory, the perforant
path originates from layers II and III in the entorhinal
cortex. It then projects into the angular bundle towards
the pyramidal layer of the subiculum. It then splits into
a component that projects into the dentate gyrus, while
the other part traverses inferiorly towards the hip-
pocampal CA fields. A small fraction of the perforant
path fibres at level of the angular bundle join the
alvear path [35] (Figure 1).
The subiculum and the dentate gyrus were manually
segmented and served as seed and termination masks,
respectively. The part of the perforant path that runs
from the entorhinal cortex to the subiculum (Figure 1)
is located more posterior and was not included in our
specimens. Five thousand streamlines were generated
for each seed-voxel, and only streamlines that entered
the dentate gyrus were saved. The curvature threshold
was set to 0.2, with a step length of 0.1 mm and a
minimal fibre volume threshold of 0.01. The approach
above produced probability maps of the spatial trajec-
tory of the perforant path. An empirically defined
threshold was set for the probability maps of each hip-
pocampus separately to obtain a mask of the perforant
path from which the microstructural metrics were
extracted.
Finally, partial volume effects (i.e. the mixture of
multiple tissue type within a voxel) can have a signifi-
cant impact on the diffusion signal [37]. To measure
partial volume effects in each specimen, two tissue
types (i.e. grey and white matter) were segmented
using FSL’s FAST algorithm. FAST then provided par-
tial volume estimates for the tissue types in each voxel.
Using the ROIs defined by tractography, partial volume
was extracted from the perforant path.
Tissue processing
After dMRI, all nineteen hippocampus blocks were
bisected along the coronal plane into two approximately
equal parts. One part was processed for paraffin embed-
ding for IHC analysis. The other part was frozen for
polarized light imaging (PLI) after cryoprotection with
30% sucrose in PBS. Frozen sections are preferred for PLI
as the lipids in the myelin sheath remain preserved.
Polarized light imaging
Using PLI, we can estimate the orientation and density
of myelinated fibres in thin tissue sections, due to the
interaction of polarized light with myelin birefringence.
The theory behind the polarimetric set-up is extensively
described elsewhere [24,38].
All frozen tissue blocks were sectioned at 50 lm
thickness on a freezing microtome (Microm HM 440E
Microtome). The sections were mounted on glass slides
and coverslipped with polyvinylpyrrolidone mounting
medium. PLI images were acquired on a Zeiss Axio
Imager A2 microscope upgraded with a stationary
polarizer, a quarter wave plate and a rotating polarizer.
Light first passes through the stationary polarizer and a
quarter wave plate positioned in a 45° angle relative to
the stationary polarizer to create circularly polarized
light. The polarized light then passes through the hip-
pocampal sections undergoing a phase shift caused by
birefringence of myelin, and finally through the rotat-
ing polarizer. To quantify the phase shift, which reflects
the in-plane orientation of fibres, images were acquired
at nine equiangular orientations of the rotating polar-
izer from 0° to 160° with a CCD camera (Axiocam,
Zeiss). Together with a 1.09 magnifying objective, this
yielded a spatial resolution of ~4 lm/pixel. A set of
background images was acquired for every rotation
angle to correct for inhomogeneous background illumi-
nation [39]. Three parameter maps were derived by fit-
ting the light intensity at each pixel to a sinusoidal
function [40]. The phase of the sinusoid gave the in-
plane orientation of myelinated fibres. The amplitude of
the light wave provided the retardance map describing
the myelin density. The retardance and in-plane orien-
tation maps are combined in the fibre orientation map
that colour-codes the direction fibres with its intensity
modulated by the myelin density. Finally, a transmit-
tance map was calculated as the average amount of
light passing through the tissue yielding grey and
white matter contrast.
The retardance maps inform how much the phase of
the light wave is shifted due to interaction with myelin
and is therefore used to evaluate the amount of myelin
within a section. A decrease in the retardance values
may therefore be a marker of myelin loss. The per-
forant path was manually delineated using a composite
of the PLI transmittance and retardance maps for each
specimen separately (Figure S1). This was defined as
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the white matter originating from the subiculum and
partly projecting through CA1, along and into the den-
tate gyrus (Figure 3).
Immunohistochemistry
Immunohistochemistry staining of the hippocampus
sections was carried out to identify disease-specific
changes in microstructure. Antibodies against several
proteins were used; proteolipid protein (PLP) for myelin,
SMI-312 for axonal phosphorylated neurofilaments,
cluster of differentiation 68 (CD68) for activated micro-
glia and lastly pTDP-43. Paraffin-embedded tissue
blocks were sectioned at 6 lm for the PLP, SMI-312
and CD68 stains. Sections stained for pTDP-43 were
cut at 10 lm. The sections were then mounted on
Superfrost Plus slides (ThermoFisher, Art. No.
J1800BMNZ). The sections were deparaffinized in
xylene and rehydrated through a series of 100%,
100%, 90% and 70% ethanol. The endogenous peroxi-
dase was blocked by incubating the sections 3% H2O2
in PBS for 30 minutes. Subsequently, antigen-binding
sites for pTDP-43 and CD68 were retrieved by auto-
claving in citrate buffer (pH = 6). Antigen retrieval for
PLP and SMI-312 was achieved through heating the
sections submerged in citrate buffer (pH = 6) in a
microwave. After antigen retrieval, the sections were
washed with PBS. After washing, the primary antibody
was added. All primary antibodies were diluted in TBS/
T (pH = 7.6). The primary antibodies against PLP
(1:1000, Bio-Rad, MCA839G), CD68 (1:200, Dako
Denmark, M0876) and SMI-312 (1:2000, BioLegend,
837901) were incubated for 1 hour at room tempera-
ture. The primary antibody against pTDP-43 (1:40
000, CosmoBio, TIP-PTD-M01) was incubated over
night at 4°C. After washing, the secondary antibody
containing HRP rabbit/mouse serum (DAKO EnVision
Detection Systems) was added and incubated for
1 hour. A DAB substrate buffer solution was subse-
quently added (DAKO EnVision Detection Systems) and
incubated for 5 min. Sections were washed with PBS to
stop the reaction. Finally, a counterstain with haema-
toxylin was performed to visualize the nuclei. After
counterstaining, the sections were washed, dehydrated
and mounted with DPX.
Immunohistochemistry sections were digitized on an
Aperio ScanScope AT Turbo slidescanner employing a
209 magnifying objective (409 for the pTDP-43
sections). pTDP-43 sections were judged by two neu-
ropathologists (OA and MPG) to determine any TDP-43
pathology in the dentate gyrus for FTD-TDP pro-
teinopathy. The other stains (PLP, SMI-312 and CD68)
were computationally segmented in Matlab (Math-
Works Inc., Natick, USA) making use of colour contrast
between the DAB-stain and the haematoxylin counter-
stain. Following common practice in IHC analysis, the
area fraction of the IHC stains was used to quantify the
protein of interest. To achieve this, the images were
first transformed to HSV colour-space. A colour range
for the brown DAB-staining was interactively deter-
mined in the hue-channel (H) using Matlab’s colour-
segmentation application. Furthermore, an intensity
threshold was applied in the saturation-channel (S).
The colour and intensity threshold were used together
to isolate the brown DAB-staining from the back-
ground. However, to account for varying staining
intensity across specimens, the intensity thresholds
were determined for each specimen separately. The
intensity threshold was automatically determined by
measuring the average intensity in the saturation-
channel from a region within the collateral white mat-
ter in each specimen. Nontissue pixels were likewise
identified as bright white pixels that were not labelled
DAB-staining, nor the haematoxylin counterstain.
Finally, a stained area fraction was calculated as the
ratio of DAB-positive pixels over all tissue pixels
within a local neighbourhood of 100 9 100 pixels.
The perforant path area was manually drawn in all
slices separately. Following a similar strategy as with
PLI, these regions-of-interest were defined as the white
matter originating from the subiculum and partly pro-
jecting through CA1, along and into the dentate
gyrus (Figure S1).
Statistics
All statistical analyses were carried out in Matlab
(MathWorks Inc. Natick, MA). We constructed a gen-
eral linear model (GLM) that tested for group differ-
ences (similar to a student’s t-test) among the dMRI
microstructural metrics (FA, MD, RD and AD). To
assess whether microstructural differences were driven
by partial volume effects, the GLM included the tissue
partial volume estimates from the FAST algorithm as a
covariate. Between the groups, there was a significant
difference in fixation time (P = 0.003). As it is known
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that fixation time and post mortem interval can cause a
reduction in FA and diffusivity [41,42], a normalization
step was performed before calculating the t-statistics.
The normalization was done by dividing the found
dMRI metrics in the perforant path by a reference value
for each of these metrics in a control region – collateral
white matter – within the same sample.
A one-tailed student’s t-test was applied to evaluate
PLI retardance values in the perforant path. To assess
whether changes in diffusion tensor metrics were dri-
ven by myelination, a Pearson correlation (two-tailed)
was performed between both FA and MD, and PLI
retardance.
Finally, one-tailed t-test was again used quantify dif-
ferences in IHC staining between ALS and controls.
PLP myelin estimates were correlated against SMI-312
neurofilaments, PLI retardance and dMRI FA (Pearson,
two-tailed).
With ALS and FTD forming a disease spectrum, the
heterogeneity of metrics within the disease group is
expected to be large. As such, the correlation analyses
may unravel relationships that extend across all sub-
jects; for example, between dMRI and myelin integrity.
Results
MRI
Diffusion MRI was acquired from all subjects, but one
ALS case was excluded from further analysis due to
insufficient contrast and noisy images. The perforant
pathway was reconstructed for all other hippocampus
specimens from the dMRI data by employing probabilis-
tic tractography. The probability maps of the perforant
path from two control and two ALS cases are depicted
as illustrative examples in Figure 2a. Tracts are shown
from the subiculum to the dentate gyrus; the part from
entorhinal cortex to subiculum was not included in the
hippocampus specimens. An arbitrary probability
threshold was applied for each specimen separately to
create the maps. However, sometimes tractography
delineates tracts propagating directly into the dentate
gyrus and continue traversing through the dentate
gyrus (Figure 2a, control case, left). For the majority
of the cases, tractography reconstructed fibres from
the subiculum to CA1 and then into the dentate
gyrus. These regions defined by the probability maps
were used to extract the diffusion tensor metrics and
to get an impression of white matter degeneration along
the perforant paths in ALS cases and controls (see
Figure 2b).
Within the perforant path, the FA values were signif-
icantly lower in ALS specimens compared to controls
(P = 0.013). A reduced FA is caused by water diffusing
more isotropically (less directionally) and possibly indi-
cates myelin degeneration or an increase in interstitial
spaces. This hypothesis is further strengthened by the
increase that was found in MD in ALS specimens com-
pared to controls (P = 0.015). In addition, both AD
(P = 0.026) and RD (P = 0.026) values were signifi-
cantly higher in ALS cases compared to controls. An
increase in RD might be caused by an increasing
amount of diffusion along the radial diffusion direction,
again consistent with loss or atrophy of fibres. The
model including partial volume effects did not identify
a significant effect of partial volume (0.07 < P < 0.45);
moreover, inclusion of partial volume as a confound
regressor did not change the pattern of a significant dif-
ference between groups reported in Figure 2.
Polarized light imaging
Figure 3 depicts an example of the transmittance, retar-
dance and fibre orientation maps from a control sample.
White matter is easily recognized in the retardance maps,
appearing bright due to birefringence in the myelin
sheath. Several subareas of the hippocampal formation
are delineated in the fibre orientation map, including the
approximate trajectory of the perforant path.
PLI retardance maps were used as a semiquantitative
measure of myelin density. Example retardance maps
from a control case and an ALS case are shown in Fig-
ure 4, demonstrating lower retardance values in the per-
forant path area for the ALS case. Across all samples, the
retardance values appeared to be lower in the perforant
paths in ALS (P = 0.05). The correlation analysis
revealed a significant association between FA and retar-
dance (r = 0.52, P = 0.04). This may indicate that
reduced FA is driven by a loss of myelinated axons in the
perforant path. No significant correlation was found
between retardance and MD (r = 0.34, P = 0.48).
Immunohistochemistry
Immunohistochemistry was successfully carried out in
all hippocampus specimens. Two out of the fourteen
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ALS cases demonstrated FTD-TDP proteinopathy in the
dentate gyrus (Figure 5). The automatic segmentation
of the myelin (PLP), neurofilaments (SMI-312) and
activated microglia (CD68) images was deemed suitable
for semiquantification of these IHC markers (Figure 6).
Following up on the white matter alterations reported
with dMRI and PLI, levels of myelin and neurofila-
ments were compared between controls and ALS
patients. Indeed, less myelin was found in the perforant
path of ALS patients (P = 0.03). Also, the stained area
fraction of neurofilaments was lower in ALS
(P = 0.02). No changes were observed in the amount
of CD68 in both groups (Figure 7). To see if reduced
levels of PLI retardance and dMRI FA were driven by
lowered levels of myelin, a correlation analysis across
all specimens was performed. Neurofilaments area
Figure 2. Perforant path microstructure estimated from diffusion Magnetic Resonance Imaging (dMRI) data. (a) Tractography in the
perforant pathway running from the subiculum to the dentate gyrus for two controls and two amyotrophic lateral sclerosis (ALS) cases.
These tracts were used for extracting the mean diffusivity (MD), radial diffusivity (RD), axial diffusivity (AD) and fractional anisotropy
(FA) values within the perforant path. Tracts are superimposed on the T1-weighted anatomical scan. (b) The FA value in the part of the
perforant path that runs from the subiculum to the dentate gyrus is lower in ALS cases compared to controls (P = 0.013). The MD value
is significantly higher in the perforant path in the ALS specimen compared to controls (P = 0.015) as well as the AD (P = 0.026) and
the RD (P = 0.026). All P-values given for a one-tailed t-test. The boxplot centre lines depict the median for each metric; box limits, the
25th and 75th percentiles of the metrics; the whiskers extend to the most extreme data points excluding outliers; raw data points are
given by the black dots.
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fractions were lower in subjects with reduced myelin
area fraction (r = 0.71, P = 0.001). Additionally, a
positive correlation was found between IHC myelin and
(1): PLI retardance (r = 0.51, P = 0.03) and (2): dMRI
FA (r = 0.52, P = 0.03). The two ALS-FTD cases
expressed lowered levels of myelin in comparison to all
other ALS cases, but these were not significantly differ-
ent (Figure 7). CD68 area fractions in ALS-FTD were
also similar compared to other ALS cases.
Discussion
Amyotrophic lateral sclerosis is mostly known as a
motor neuron disease; the corticospinal tract and the
corpus callosum are frequent targets for studies investi-
gating white matter alterations in ALS [43–46]. How-
ever, ALS is increasingly recognized as a multisystem
neurodegenerative disorder, that may be associated
with clinical bvFTD. As such, white matter alterations
were studied in the perforant path, a component of the
Papez circuit, as evidence for ALS being a multisystem
disorder [47].
First, the results warrant some justification for the
location of the perforant path delineated by tractogra-
phy. For the majority of the cases, tracts were
reconstructed from the subiculum, to CA1 and then to
the dentate gyrus, in agreement with anatomical
descriptions of the perforant path [32–34]. However,
within these tractography maps, we cannot distinguish
individual fibres traversing either from the subiculum
directly to the dentate gyrus or those travelling via the
hippocampal CA1 field into the dentate gyrus. For some
cases, there was a clear direct connection between the
subiculum to the dentate gyrus (Figure 2a, control
case, left), with tractography propagating through the
dentate gyrus. Both scenarios have been reported previ-
ously using probabilistic tractography in post mortem
human brains [23]. Nevertheless, tractography results
require careful interpretation; its pitfalls are well
described in other studies [48] and the MRI community
is actively trying to overcome these limitations [49]. By
no means can we consider tractography as a replace-
ment for tracer injections in animals. Evaluation
against reference material – for example microscopy
data – is therefore always desired.
Using diffusion MRI, we demonstrated a reduction in
fractional anisotropy (FA) and an increase in diffusivity
markers (MD, AD and RD) in the perforant path in ALS
(Figure 2), all suggesting white matter degeneration
[51,52]. However, in the presence of demyelination
Figure 3. Polarized light imaging data from a control case. The transmittance map reflects the amount of light passing through the
tissue. The retardance map shows the degree to which the light is shifted due to interaction with the myelin. The fibre orientation map
colour-codes the directionality of the myelinated fibres indicated by the colour wheel. This map is formed by combining the retardance
and in-plane map. The anatomical regions within the hippocampus are delineated and the approximate direction of the perforant path is
indicated with the yellow arrows. Circled-cross represents anterior-posterior direction of the perforant path. The maps are a composite of
multiple field-of-views. CA, cornu ammonis; DG, dentate gyrus; EC, entorhinal cortex; PreSub, presubiculum and Sub, subiculum. Scale-
bar = 3 mm.
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and white matter loss, AD has also been reported to
remain unaffected [53,54]. Possibly, an increase in AD
is observed due to enlargement of the extracellular
space as a result of axonal degeneration. While the
dMRI results suggest that white matter in the perforant
path is damaged in ALS cases, changes in the dMRI
metrics can also be driven by several other factors.
dMRI microstructure estimates are inferred from local
Figure 4. Polarized light imaging retardance – reflecting myelin density – in the perforant path. The upper part of the figure depicts two
exemplar retardance maps from a control – and an amyotrophic lateral sclerosis (ALS) case. Here, the red arrows indicate the
approximate location of the perforant path. Retardance was significantly lower in ALS patients compared to controls. Furthermore, the
changes in fractional anisotropy (FA) were possibly driven by myelin density, supported by significant correlation between FA and
retardance were significantly correlated across all subjects. A correlation between mean diffusivity (MD) and retardance was not found.
See caption Figure 2 for boxplot description. Scale-bar = 3 mm.
Figure 5. pTDP-43 pathology in the granule cell layer (gcl) of the dentate gyrus. Cases were stratified by absence (a) or presence (b) of
pTDP-43 inclusions (coloured brown) in the granule cells of the dentate gyrus. Blue nuclei. Scale-bar = 50 lm.
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diffusion of water in tissue and are therefore indirect
measures of the white matter geometry. Rather than an
altered microstructural signature due to disease, it is pos-
sible that some changes are driven by variations in anat-
omy across subjects. Furthermore, death, tissue fixation
and post mortem interval all affect the microstructural
metrics estimated here. For instance, a significant differ-
ence was observed in fixation times between the control
and ALS group (P = 0.003), which is known to decrease
diffusivity in tissue [41,42,55,56]. We accounted for
these fixation time differences by normalizing the dMRI
measures with a control region in collateral white
matter.
Partial volume effects – reflecting intravoxel hetero-
geneity of tissue types – can also be a significant con-
founding factor in age or disease-related dMRI analyses
[50]. After estimating partial volume in the perforant
path and including it in our modelling to evaluate
microstructural group differences, we concluded that
partial volume effects had no significant effect on the
outcomes (Figure 2).
Finally, as dMRI measures are affected by death and
fixation, one ideally would perform in vivo dMRI of the
perforant path in control and disease groups. Using
current clinical MR systems – typically having field
strengths of 1.5-3T – this remains challenging; with
limited scan times (<1 h) for patients, obtaining suffi-
cient resolution to image small structures such as the
perforant path is currently infeasible with dMRI. The
use of ex vivo tissue allowed us to employ long scan
times (3–4 h) and an ultra-high field MRI scanner
(11.7T) resulting in very high-resolution dMRI. Never-
theless, promising progress in this area is currently
made by obtaining in vivo dMRI with whole-brain cov-
erage at submillimetre resolution [57].
Polarized light imaging is a relatively novel imaging
modality and to date primarily applied to study neu-
roanatomy [58,59], interpret dMRI fibre orientations
Figure 6. Histological data processing. The left column shows stained sections with a snapshot for myelin (PLP), neurofilaments (SMI-
312), and activated microglia (CD68). The middle column depicts the segmentation of the images in the left column. A colour-based
segmentation was applied to separate DAB-stain-positive pixels (red) from the background tissue (black) and nontissue pixels (white).
After processing, the stained area fraction was calculated per 100 9 100 pixels resulting in a down-sampled image reflecting the stained
area fraction over the entire slice (right column). Scale-bar = 30 lm.
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in grey matter [60] or evaluate dMRI-derived fibre dis-
persion [61]. In particular, hippocampal fibre systems
have been visualized with PLI previously [35], demon-
strating excellent use of the technique to study con-
nectivity at mesoscopic scale. However, its application
to study white matter degeneration is, to our knowl-
edge, new and its results should therefore be inter-
preted with care. We found a decrease in retardance
values in the perforant paths of ALS specimens (Fig-
ure 4). Retardance reflects myelination and thus a
reduction could indicate a loss of myelinated axons.
However, PLI retardance is not exclusively sensitive to
birefringence of the myelin sheath; it also decreases
with an increasing fibre inclination (out-of-section)
angle. Yet, the hippocampal specimens in this study
were carefully sectioned in the same orientation keep-
ing variations in fibre inclination angles in the per-
forant to a minimum. Therefore, we can ascribe
differences in retardance primarily to birefringence
and thus myelination.
While the dMRI and PLI outcomes suggested white
matter degeneration in the perforant path of the ALS
specimens, the gold standard remains IHC in these
types of analyses. The stained area fractions of both
myelin and the neurofilaments were lower in ALS com-
pared to controls (Figure 7). PLP is one of the most
abundant myelin proteins in the central nervous sys-
tem [62] and demyelination would result in a reduc-
tion of PLP estimates [63]. Loss of neurofilaments
indicates neuroaxonal damage and its breakdown pro-
duct in the blood or cerebrospinal fluid is a suitable bio-
marker for various acute and chronic neurological
disorders [64]. A loss of neurofilaments was correlated
with reduced myelin density in the perforant path.
Also, it is likely that the changes observed in dMRI
(lowered FA) and PLI (reduced retardance) are driven
Figure 7. Immunohistochemistry in amyotrophic lateral sclerosis (ALS) and controls. The stained area fraction of myelin (PLP) and
neurofilaments (SMI-312) was significantly lower in the perforant paths of ALS patients compared to controls. The area fractions of
activated microglia (visualized with CD68; marker for inflammation) were similar in both groups. Two out of the fourteen ALS cases
exhibited pTDP-43 pathology within the dentate gyrus, used for neuropathological characterization of FTD. Furthermore, myelin area
fractions from the immunohistochemistry stains correlated with myelin density estimated from the polarized light imaging retardance
maps and also with FA derived from diffusion Magnetic Resonance Imaging (dMRI). The two ALS-FTD cases had lowered myelin density
estimates, but no difference was observed compared to pure ALS cases. See caption Figure 2 for boxplot description.
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by the white matter degeneration of the perforant path;
a positive correlation was found between IHC myelin
and both dMRI metrics (Figure 7). The relatively high
correlation between the modalities provides some confi-
dence that the annotated regions correspond among
the techniques used here.
In the hippocampus, or in the granule cell layer of
the dentate gyrus in particular, pTDP-43 pathology is
present in late stage of ALS and early stages of FTD
[7]. Although the two ALS-FTD cases were on the
lower spectrum of myelination levels within the ALS
group, no evidence was found for extreme white matter
degeneration as a result of pTDP-43 pathology in the
dentate gyrus. Nevertheless, the fact that white matter
degeneration was present in almost all ALS, may sug-
gest that loss of (myelinated) neurofilaments is present
before the onset of pTDP-43 pathology in the hip-
pocampus or entorhinal cortex. Furthermore, the fact
that most ALS cases were diagnosed with stage 1 at
time of death (Table 1), suggests that pTDP-43 pro-
teinopathy is not necessarily a marker for the symp-
tomatic severity of ALS. This largely agrees with
studies showing no correlation between disease dura-
tion/progression and pTDP-43 burden [13].
Immunohistochemistry analysis showed no differ-
ences in the amount of activated microglia – a measure
of neuroinflammation – in ALS cases compared to con-
trols. This is somewhat surprising as white matter
degeneration is associated with increased microglial
activation [65]. Indeed, motor connectivity in the cor-
pus callosum and the corticospinal tract previously
showed enhanced levels of microglial activation in ALS
[66,67]. However, inflammation is a complex system in
the brain and there are variety of processes that may
drive neuroinflammatory responses [68]. A marker
such as IBA-1 (ionized calcium-binding adapter mole-
cule 1) is also frequently applied to estimate neuroin-
flammation in tissue and may have produced different
outcomes [69].
Thus far, only a segment of the perforant path as
being part of the Papez circuit was investigated. Future
research should also include imaging of the other
Papez circuit regions to get a better understanding of
the disease’s progression in areas such as the anterior
cingulate cortex, fornix, mammillary bodies and the
anterior thalamus. Our data would benefit from the
inclusion of quantitative cognitive assessment scores
for each patient. However, we postulate that
neuropathological staging of pTDP-43 pathology can
be used as a surrogate marker for the likelihood of pro-
gression towards FTD for each case. The current study
supports evidence that the perforant path undergoes
degeneration, a feature that substantiates evidence for
the cognitive deficits observed in some ALS patients.
Some more insight might be gained from the relation-
ship between perforant path degeneration and clinically
observed cognitive decline.
Conclusion
This work investigated white matter changes in the
perforant path in ALS patients using dMRI, PLI and
IHC analyses as a possible marker for FTD develop-
ment. A reduction in the FA and an increase in the
MD, AD and RD observed in all ALS cases relative to
controls, implicating white matter degeneration of the
perforant path. This observation was supported by a
decrease in the PLI retardance values measuring mye-
lin density in the perforant path. IHC confirmed the
results from dMRI and PLI by reporting a decrease in
myelin and neurofilaments. We conclude that degener-
ation of the perforant path occurs in ALS patients and
that this may occur before, or independent of, pTDP-43
aggregation in the dentate gyrus of the hippocampus.
This provides further evidence of ALS being a multisys-
tem disease, and involvement of the perforant path sup-
ports a link between ALS and FTD. Finally, our results
warrant future investigations of the perforant path as a
candidate neural MRI correlate of the cognitive symp-
toms in ALS.
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Supporting information
Additional Supporting Information may be found in the
online version of this article at the publisher’s web-site:
Figure S1. Regions-of-interest for the perforant path in
the hippocampus specimens for two control and two
amyotrophic lateral sclerosis (ALS) cases. (a) Diffusion
Magnetic Resonance Imaging (MRI) tractography run-
ning from the subiculum to the dentate gyrus. For the
microscopy data, all perforant path regions were manu-
ally annotated, inspired by the location outlined by trac-
tography. (b) For polarized light imaging, the masks are
shown on the transmittance images, that are in the
same space as the retardance images. Furthermore, the
perforant path annotations are shown for the myelin (c)
and neurofilament (d) immunohistochemistry images.
Table S1. Brain regions sampled and sampled for diag-
nostic purposes in accordance with the standard brain
bank protocol of the Oxford Brain Bank, Nuffield Depart-
ment of Clinical Neurosciences, University of Oxford.
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